Skip to content
MarketScale
‹ Back to IndustriesHealthcare

How to Approach Sustainability in Healthcare Design: Build for Impact

A proponent of lifelong learning, Daniel A. Huard is a sought‐after green building expert also recognized as the Godfather of sustainability. Huard is launching Build For Impact, aiming to build a platform to allow for collaboration with some of the best minds in the world who focus on green design and sustainability. Building has long been a part of…

This story was produced through MarketScale. See how Healthcare teams put it to work with Executive Thought Leadership.

Share
How to Approach Sustainability in Healthcare Design: Build for Impact

Get featured

Want to get featured in MarketScale Healthcare?

Create a free MarketScale workspace and get your company's expertise featured across our Healthcare coverage. No credit card, no demo required.

Start free

A proponent of lifelong learning, Daniel A. Huard is a sought‐after green building expert also recognized as the Godfather of sustainability. Huard is launching Build For Impact, aiming to build a platform to allow for collaboration with some of the best minds in the world who focus on green design and sustainability.

Building has long been a part of the human experience. It’s been a critical aspect in the evolution of life. Now construction and design are more than just about how it looks and how it works. The new horizon is focusing on sustainability, resilience, and material transparency. To lend expertise on the subject, architect Jane Rohde, Principal at JSR Associates, with a list of distinguished awards and certifications, joins Hthe show.

Sustainability is a buzzword in architecture, but what does it really mean right now? Rohde shared, “Sustainability isn’t a single attribute. It’s integrated together. Being in healthcare, I see this more prominently, the unintended consequences of not looking at performance.”

Alongside sustainability comes resiliency, which describes the ability of a building to prevent and recover from damage. “Resiliency now really ties into emergency preparedness. Looking at nursing homes hit hard by COVID or how hospitals on the Texas coast prepared for Hurricane Harvey. If design intention and operation intention are considered together, it’s a much better outcome,” Rohde commented. 

Another critical subject is material transparency. To be fully transparent is difficult for manufacturers and supply chains. It’s not just what the product is; it’s where it’s from and the conditions of that area.

“With material transparency, there are bigger questions that we don’t have answers to, regarding social responsibility. But the conversations are happening. What’s critical is not to look at it from a single attribute perspective. The better way may be from an exposure and risk perspective,” Rohde stated.

Listen To Previous Episodes of Build for Impact Right Here!

Your experts belong here

Every story in MarketScale Healthcare starts with a company putting its clinicians, service-line leaders, and field engineers on the record. Buyers are already reading this topic. The only question is whose experts they find.

Service-line buyers vet vendors quietly, and your clinicians become the proof they find while doing it.

Get your team featuredSee how it works15 minutes, straight to a calendar.
B2B Weekly

The week in Healthcare, and sixteen other industries, every Monday.

Ten stories, one-line takes, five minutes. Free.

Healthcare: are you visible to AI?

Before they reach out, Healthcare buyers ask AI engines which vendors to trust. Explore how your experts, customers, and partners can become useful content for buyers and AI search.

Free plan

You just read one Healthcare expert. Your company is full of them.

This article was produced through MarketScale. The same platform turns your clinicians, service-line leaders, and field engineers into the articles, video, and social content Healthcare buyers are searching for. Create a free workspace and see it with your own people. No credit card, no demo required.

NPS +73 · 1,000+ creators · 38+ countries

What you get, free

Your own MarketScale workspace, up to 10 people
One professional video edit a month for qualifying companies
Media requests to your crowd, remote recording, AI writing tools
$0, no credit card, nothing that expires

More Healthcare Insights

NICE recommends Enhertu for HER2-low advanced breast cancer in England

NICE recommends Enhertu for HER2-low advanced breast cancer in England

American Pharmaceutical Review reported that NICE has recommended Enhertu for routine NHS use in people with HER2-low advanced breast cancer, following a commercial agreement and updates to NICE’s methods under the U.K.-U.S. Pharmaceutical Pricing Agreement.

  • 01NICE tied the reversal to 2026 changes: higher cost-effectiveness thresholds that took effect in April and a new quality-of-life assessment method published Aug. 27, 2026.
  • 02Access planning still varies by nation: Fierce Pharma reported Wales requires funding within 60 days of final guidance, while Scotland and Northern Ireland follow separate processes.

Sep 21, 2026

Eli Lilly’s $6.5B Houston Bet Highlights U.S. Pharma Reshoring

Eli Lilly’s $6.5B Houston Bet Highlights U.S. Pharma Reshoring

Eli Lilly has broken ground on a $6.5 billion manufacturing facility in Houston, slated for completion around 2030. While attention has focused on scaling production of Foundayo, its oral GLP-1 treatment, the project also reflects broader U.S. efforts to rebuild domestic pharmaceutical manufacturing and highlights the supply chain challenge of forecasting demand and building capacity years in advance.

  • 01Eli Lilly commits $6.5 billion to a Houston pharmaceutical manufacturing facility due for completion around 2030, one of the largest single U.S. pharma production investments in recent years
  • 02GLP-1 demand forecasting remains highly uncertain, making it difficult to commit billions to manufacturing capacity years before demand and required output are clear.
  • 03Houston's selection reflects industrial capacity and workforce depth, positioning the region as a biomanufacturing corridor and creating long-term hiring demand in engineering, quality control, and skilled trades

Sep 21, 2026

NextGen Invent’s Deepak Mittal argues for scoped healthcare AI pilots with early governance

NextGen Invent’s Deepak Mittal argues that healthcare AI pilots can begin with a reliable data subset and early governance. His performance figures are vendor claims, not independently verified results.

  • 01Deepak Mittal advocates starting with a defined problem and suitable data rather than waiting for perfect organization-wide data.
  • 02Some performance figures cited in the interview (for example, preparation time and model counts) are company-reported and not independently verified in this article.
  • 03NIST’s voluntary AI Risk Management Framework provides an independent structure for governance and risk evaluation.

Sep 21, 2026

Explore More Healthcare Insights

Read more expert perspectives from across Healthcare.

Browse Healthcare Hub

For B2B teams

Your experts could be publishing here

Stories like this one run on content MarketScale captures from real practitioners. See how your team's expertise becomes coverage in Healthcare and beyond.

Book a 15-minute demo

Or call us. No forms required. We pick up. 214-945-2512